Location History:
- Hittarp, SE (1976 - 1977)
- Helsingborg, SE (1979)
Company Filing History:
Years Active: 1976-1979
Title: Imre Konyves: Innovator in Pharmaceutical Chemistry
Introduction
Imre Konyves is a notable inventor based in Hittarp, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with antitumor activity. With a total of 4 patents to his name, Konyves has established himself as a key figure in his area of expertise.
Latest Patents
Konyves' latest patents include innovative compounds that demonstrate potential in cancer treatment. One of his notable inventions is the "Novel 17-esters of 17.alpha.-hydroxy gestogens, compositions containing," which relates to novel 17.alpha.-esters of gestogens that exhibit antitumor activity. This invention also encompasses pharmaceutical compositions containing these compounds and methods of treatment utilizing them. Another significant patent is for "Novel enol esters of steroids, compositions containing such compounds," which similarly focuses on enol esters of steroids with antitumor properties and their preparation, along with related pharmaceutical compositions and treatment methods.
Career Highlights
Konyves is associated with Aktiebolaget Leo, where he has been instrumental in advancing research and development in pharmaceutical applications. His work has contributed to the understanding and potential treatment of various cancers through innovative chemical compounds.
Collaborations
Throughout his career, Konyves has collaborated with esteemed colleagues, including Hans Jacob Fex and Bertil Hansen. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Imre Konyves is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in cancer treatment. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.